摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R)-3-(5-chloro-2-methoxypyridin-4-yl)sulfanyl-3-(1,2-oxazol-5-yl)propan-1-amine

中文名称
——
中文别名
——
英文名称
(3R)-3-(5-chloro-2-methoxypyridin-4-yl)sulfanyl-3-(1,2-oxazol-5-yl)propan-1-amine
英文别名
——
(3R)-3-(5-chloro-2-methoxypyridin-4-yl)sulfanyl-3-(1,2-oxazol-5-yl)propan-1-amine化学式
CAS
——
化学式
C12H14ClN3O2S
mdl
——
分子量
299.78
InChiKey
GYJGPKCAEBRLDL-SNVBAGLBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    99.5
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • HETEROARYLHETEROALKYLAMINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NITRIC OXIDE SYNTHASE
    申请人:AstraZeneca AB
    公开号:EP1414802B1
    公开(公告)日:2006-04-26
  • JP2005501834A
    申请人:——
    公开号:JP2005501834A
    公开(公告)日:2005-01-20
  • Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
    申请人:——
    公开号:US20040176422A1
    公开(公告)日:2004-09-09
    There are provided novel compounds of formula (I), wherein R 1 , R 2 , R 3 , Q, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain.
  • [EN] HETEROARYLHETEROALKYLAMINE DERIVATIVES AND THEIR USE AS INHIBITORS OF NITRIC OXIDE SYNTHASE<br/>[FR] DERIVES D'HETEROARYLHETEROALKYLAMINE, ET LEUR UTILISATION COMME INHIBITEURS DE LA SYNTHASE DU MONOXYDE D'AZOTE
    申请人:ASTRAZENECA AB
    公开号:WO2003011830A1
    公开(公告)日:2003-02-13
    There are provided novel compounds of formula (I). wherein R?1, R2, R3¿, Q, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain.
查看更多